GRECCAR 14 - a multicentric, randomized, phase II-III study evaluating the tailored management of locally advanced rectal carcinoma after a favourable response to induction chemotherapy: study protocol

CONCLUSION: If GRECCAR 14 demonstrates the ability to tailor TNT for LARC, this could lead to changes in clinical practice.PMID:37697712 | DOI:10.1111/codi.16740

Source: Cancer Control - September 12, 2023 Category: Cancer & Oncology Authors: Philippe Rouanet Florence Castan Thibault Mazard Claire Lemanski Stephanie Nougaret Emmanuel Deshayes Patrick Chalbos Sophie Gourgou Christophe Taoum GRECCAR, PRODIGE study group Source Type: research